Table 1 Characteristics of the study population.
Characteristics | Total (n = 98,270) | Age at blood measurement 39–59 years (n = 63,780) | Age at blood measurement 60–79 years (n = 32,056) | Age at blood measurement ≥ 80 years (n = 2434) |
|---|---|---|---|---|
Age at baseline, mean (SD) | 57.1 (9.7) | 51.2 (4.8) | 66.7 (5.4) | 83.1 (3.0) |
Female sex, n (%) | 45,978 (46.8) | 26,961 (42.3) | 17,266 (53.9) | 1751 (71.9) |
Lipid biomarkers at baseline, mean (SD) | ||||
TC, mmol/L | 6.22 (1.16) | 6.14 (1.13) | 6.40 (1.18) | 6.14 (1.22) |
Triglycerides, mmol/L | 1.43 (0.81) | 1.40 (0.82) | 1.49 (0.79) | 1.41 (0.75) |
ApoB, g/L | 1.34 (0.34) | 1.33 (0.34) | 1.37 (0.35) | 1.26 (0.34) |
ApoA-I, g/L | 1.47 (0.23) | 1.46 (0.23) | 1.48 (0.34) | 1.49 (0.35) |
ApoB/ApoA-I ratio | 0.94 (0.28) | 0.94 (0.29) | 0.95 (0.28) | 0.87 (0.26) |
History of CVD at baseline, n (%) | 9319 (9.5) | 3159 (5.0) | 5457 (17.0) | 703 (28.9) |
Coronary heart disease | 4707 (7.8) | 1384 (2.2) | 2940 (9.2) | 383 (15.7) |
Heart failure | 1299 (1.3) | 176 (0.3) | 800 (2.5) | 253 (10.4) |
Atrial fibrillation | 1372 (1.4) | 348 (0.6) | 858 (2.7) | 166 (6.8) |
Ischemic stroke/TIA | 1488 (1.51) | 351 (0.6) | 985 (3.1) | 152 (6.2) |
Hypertension | 2553 (2.6) | 952 (1.5) | 1449 (4.5) | 152 (6.2) |
Diabetes | 1552 (1.6) | 588 (0.9) | 858 (2.7) | 106 (4.4) |
Follow-up time, mean (SD) | 18.0 (6.0) | 19.8 (5.0) | 15.4 (6.3) | 7.8 (4.7) |
Age at death, mean (SD) | 77.3 (10.3) | 67.8 (7.5) | 81.4 (7.1) | 91.4 (4.6) |
Deaths (all causes) during follow-up, n (%) | 30,730 (31.3) | 10,863 (17.0) | 17,650 (55.1) | 2217 (91.1) |
Cardiovascular deaths during follow-up, n (%) | 18,135 (18.5) | 5234 (8.2) | 11,313 (35.3) | 1588 (65.2) |
